Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease

Fernando Rizzello, Ignazio Olivieri, Alessandro Armuzzi, Fabio Ayala, Vincenzo Bettoli, Luca Bianchi, Luca Cimino, Antonio Costanzo, Antonio Cristaudo, Salvatore D’Angelo, Marco Daperno, Anna Chiara Fostini, Mauro Galeazzi, Michele Gilio, Paolo Gionchetti, Paolo Gisondi, Ennio Lubrano, Antonio Marchesoni, Annamaria Offidani, Ambrogio OrlandoDaniela Pugliese, Carlo Salvarani, Raffaele Scarpa, Maurizio Vecchi, Giampiero Girolomoni

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Introduction: Immune-mediated inflammatory diseases (IMIDs) are chronic autoimmune conditions that share common pathophysiologic mechanisms. The optimal management of patients with IMIDs remains challenging because the coexistence of different conditions requires the intervention of several specialists. The aim of this study was to develop a series of statements defining overarching principles that guide the implementation of a multidisciplinary approach for the management of spondyloarthritis (SpA)-related IMIDs including SpA, psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis and uveitis. Methods: A Delphi consensus-based approach was used to identify a core set of statements. The process included development of initial questions by a steering committee, an exhaustive search of the literature using complementary approaches to identify potential statements and two Delphi voting rounds for finalization of the statements. Results: Consensus was achieved on the related nature of IMIDs, the existence of a high prevalence of multiple IMIDs in a single patient and the fact that a multidisciplinary approach can result in a more extensive evaluation and comprehensive approach to treatment. The goals of a multidisciplinary team should be to increase diagnosis of concomitant IMIDs, improve the decision-making process, and increase patient satisfaction and adherence. Early referral and diagnosis, early recognition of concomitant IMIDs and optimizing treatment to improve patient quality of life are some of the advantages of using multidisciplinary teams. To be effective, a multidisciplinary team should be equipped with the appropriate tools for diagnosis and follow-up, and at a minimum the multidisciplinary team should include a dermatologist, gastroenterologist and rheumatologist; providing psychologic support via a psychologist and involving an ophthalmologist, general practitioners and nurses in multidisciplinary care is also important. Conclusion: The present Delphi consensus identified a set of overarching principles that may be useful for implementation of a multidisciplinary approach for the management of SpA-related IMIDs. Funding: Aristea and Hippocrates.

Original languageEnglish
Pages (from-to)1-18
Number of pages18
JournalAdvances in Therapy
DOIs
Publication statusAccepted/In press - Mar 7 2018

Fingerprint

Consensus
Psoriatic Arthritis
Uveitis
Politics
Patient Compliance
Patient Satisfaction
Ulcerative Colitis
Psoriasis
Crohn Disease
General Practitioners
Autoimmune Diseases
Early Diagnosis
Decision Making
Chronic Disease
Referral and Consultation
Nurses
Quality of Life
Psychology
Therapeutics
Ophthalmologists

Keywords

  • Crohn’s disease
  • Immune-mediated inflammatory disease
  • Multidisciplinary
  • Psoriasis
  • Psoriatic arthritis
  • Spondyloarthritis
  • Ulcerative colitis
  • Uveitis

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Rizzello, F., Olivieri, I., Armuzzi, A., Ayala, F., Bettoli, V., Bianchi, L., ... Girolomoni, G. (Accepted/In press). Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease. Advances in Therapy, 1-18. https://doi.org/10.1007/s12325-018-0672-6

Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease. / Rizzello, Fernando; Olivieri, Ignazio; Armuzzi, Alessandro; Ayala, Fabio; Bettoli, Vincenzo; Bianchi, Luca; Cimino, Luca; Costanzo, Antonio; Cristaudo, Antonio; D’Angelo, Salvatore; Daperno, Marco; Fostini, Anna Chiara; Galeazzi, Mauro; Gilio, Michele; Gionchetti, Paolo; Gisondi, Paolo; Lubrano, Ennio; Marchesoni, Antonio; Offidani, Annamaria; Orlando, Ambrogio; Pugliese, Daniela; Salvarani, Carlo; Scarpa, Raffaele; Vecchi, Maurizio; Girolomoni, Giampiero.

In: Advances in Therapy, 07.03.2018, p. 1-18.

Research output: Contribution to journalArticle

Rizzello, F, Olivieri, I, Armuzzi, A, Ayala, F, Bettoli, V, Bianchi, L, Cimino, L, Costanzo, A, Cristaudo, A, D’Angelo, S, Daperno, M, Fostini, AC, Galeazzi, M, Gilio, M, Gionchetti, P, Gisondi, P, Lubrano, E, Marchesoni, A, Offidani, A, Orlando, A, Pugliese, D, Salvarani, C, Scarpa, R, Vecchi, M & Girolomoni, G 2018, 'Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease', Advances in Therapy, pp. 1-18. https://doi.org/10.1007/s12325-018-0672-6
Rizzello, Fernando ; Olivieri, Ignazio ; Armuzzi, Alessandro ; Ayala, Fabio ; Bettoli, Vincenzo ; Bianchi, Luca ; Cimino, Luca ; Costanzo, Antonio ; Cristaudo, Antonio ; D’Angelo, Salvatore ; Daperno, Marco ; Fostini, Anna Chiara ; Galeazzi, Mauro ; Gilio, Michele ; Gionchetti, Paolo ; Gisondi, Paolo ; Lubrano, Ennio ; Marchesoni, Antonio ; Offidani, Annamaria ; Orlando, Ambrogio ; Pugliese, Daniela ; Salvarani, Carlo ; Scarpa, Raffaele ; Vecchi, Maurizio ; Girolomoni, Giampiero. / Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease. In: Advances in Therapy. 2018 ; pp. 1-18.
@article{8ca020fbf34c49d3abde929aa78612d2,
title = "Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease",
abstract = "Introduction: Immune-mediated inflammatory diseases (IMIDs) are chronic autoimmune conditions that share common pathophysiologic mechanisms. The optimal management of patients with IMIDs remains challenging because the coexistence of different conditions requires the intervention of several specialists. The aim of this study was to develop a series of statements defining overarching principles that guide the implementation of a multidisciplinary approach for the management of spondyloarthritis (SpA)-related IMIDs including SpA, psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis and uveitis. Methods: A Delphi consensus-based approach was used to identify a core set of statements. The process included development of initial questions by a steering committee, an exhaustive search of the literature using complementary approaches to identify potential statements and two Delphi voting rounds for finalization of the statements. Results: Consensus was achieved on the related nature of IMIDs, the existence of a high prevalence of multiple IMIDs in a single patient and the fact that a multidisciplinary approach can result in a more extensive evaluation and comprehensive approach to treatment. The goals of a multidisciplinary team should be to increase diagnosis of concomitant IMIDs, improve the decision-making process, and increase patient satisfaction and adherence. Early referral and diagnosis, early recognition of concomitant IMIDs and optimizing treatment to improve patient quality of life are some of the advantages of using multidisciplinary teams. To be effective, a multidisciplinary team should be equipped with the appropriate tools for diagnosis and follow-up, and at a minimum the multidisciplinary team should include a dermatologist, gastroenterologist and rheumatologist; providing psychologic support via a psychologist and involving an ophthalmologist, general practitioners and nurses in multidisciplinary care is also important. Conclusion: The present Delphi consensus identified a set of overarching principles that may be useful for implementation of a multidisciplinary approach for the management of SpA-related IMIDs. Funding: Aristea and Hippocrates.",
keywords = "Crohn’s disease, Immune-mediated inflammatory disease, Multidisciplinary, Psoriasis, Psoriatic arthritis, Spondyloarthritis, Ulcerative colitis, Uveitis",
author = "Fernando Rizzello and Ignazio Olivieri and Alessandro Armuzzi and Fabio Ayala and Vincenzo Bettoli and Luca Bianchi and Luca Cimino and Antonio Costanzo and Antonio Cristaudo and Salvatore D’Angelo and Marco Daperno and Fostini, {Anna Chiara} and Mauro Galeazzi and Michele Gilio and Paolo Gionchetti and Paolo Gisondi and Ennio Lubrano and Antonio Marchesoni and Annamaria Offidani and Ambrogio Orlando and Daniela Pugliese and Carlo Salvarani and Raffaele Scarpa and Maurizio Vecchi and Giampiero Girolomoni",
year = "2018",
month = "3",
day = "7",
doi = "10.1007/s12325-018-0672-6",
language = "English",
pages = "1--18",
journal = "Advances in Therapy",
issn = "0741-238X",
publisher = "Springer Healthcare",

}

TY - JOUR

T1 - Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease

AU - Rizzello, Fernando

AU - Olivieri, Ignazio

AU - Armuzzi, Alessandro

AU - Ayala, Fabio

AU - Bettoli, Vincenzo

AU - Bianchi, Luca

AU - Cimino, Luca

AU - Costanzo, Antonio

AU - Cristaudo, Antonio

AU - D’Angelo, Salvatore

AU - Daperno, Marco

AU - Fostini, Anna Chiara

AU - Galeazzi, Mauro

AU - Gilio, Michele

AU - Gionchetti, Paolo

AU - Gisondi, Paolo

AU - Lubrano, Ennio

AU - Marchesoni, Antonio

AU - Offidani, Annamaria

AU - Orlando, Ambrogio

AU - Pugliese, Daniela

AU - Salvarani, Carlo

AU - Scarpa, Raffaele

AU - Vecchi, Maurizio

AU - Girolomoni, Giampiero

PY - 2018/3/7

Y1 - 2018/3/7

N2 - Introduction: Immune-mediated inflammatory diseases (IMIDs) are chronic autoimmune conditions that share common pathophysiologic mechanisms. The optimal management of patients with IMIDs remains challenging because the coexistence of different conditions requires the intervention of several specialists. The aim of this study was to develop a series of statements defining overarching principles that guide the implementation of a multidisciplinary approach for the management of spondyloarthritis (SpA)-related IMIDs including SpA, psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis and uveitis. Methods: A Delphi consensus-based approach was used to identify a core set of statements. The process included development of initial questions by a steering committee, an exhaustive search of the literature using complementary approaches to identify potential statements and two Delphi voting rounds for finalization of the statements. Results: Consensus was achieved on the related nature of IMIDs, the existence of a high prevalence of multiple IMIDs in a single patient and the fact that a multidisciplinary approach can result in a more extensive evaluation and comprehensive approach to treatment. The goals of a multidisciplinary team should be to increase diagnosis of concomitant IMIDs, improve the decision-making process, and increase patient satisfaction and adherence. Early referral and diagnosis, early recognition of concomitant IMIDs and optimizing treatment to improve patient quality of life are some of the advantages of using multidisciplinary teams. To be effective, a multidisciplinary team should be equipped with the appropriate tools for diagnosis and follow-up, and at a minimum the multidisciplinary team should include a dermatologist, gastroenterologist and rheumatologist; providing psychologic support via a psychologist and involving an ophthalmologist, general practitioners and nurses in multidisciplinary care is also important. Conclusion: The present Delphi consensus identified a set of overarching principles that may be useful for implementation of a multidisciplinary approach for the management of SpA-related IMIDs. Funding: Aristea and Hippocrates.

AB - Introduction: Immune-mediated inflammatory diseases (IMIDs) are chronic autoimmune conditions that share common pathophysiologic mechanisms. The optimal management of patients with IMIDs remains challenging because the coexistence of different conditions requires the intervention of several specialists. The aim of this study was to develop a series of statements defining overarching principles that guide the implementation of a multidisciplinary approach for the management of spondyloarthritis (SpA)-related IMIDs including SpA, psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis and uveitis. Methods: A Delphi consensus-based approach was used to identify a core set of statements. The process included development of initial questions by a steering committee, an exhaustive search of the literature using complementary approaches to identify potential statements and two Delphi voting rounds for finalization of the statements. Results: Consensus was achieved on the related nature of IMIDs, the existence of a high prevalence of multiple IMIDs in a single patient and the fact that a multidisciplinary approach can result in a more extensive evaluation and comprehensive approach to treatment. The goals of a multidisciplinary team should be to increase diagnosis of concomitant IMIDs, improve the decision-making process, and increase patient satisfaction and adherence. Early referral and diagnosis, early recognition of concomitant IMIDs and optimizing treatment to improve patient quality of life are some of the advantages of using multidisciplinary teams. To be effective, a multidisciplinary team should be equipped with the appropriate tools for diagnosis and follow-up, and at a minimum the multidisciplinary team should include a dermatologist, gastroenterologist and rheumatologist; providing psychologic support via a psychologist and involving an ophthalmologist, general practitioners and nurses in multidisciplinary care is also important. Conclusion: The present Delphi consensus identified a set of overarching principles that may be useful for implementation of a multidisciplinary approach for the management of SpA-related IMIDs. Funding: Aristea and Hippocrates.

KW - Crohn’s disease

KW - Immune-mediated inflammatory disease

KW - Multidisciplinary

KW - Psoriasis

KW - Psoriatic arthritis

KW - Spondyloarthritis

KW - Ulcerative colitis

KW - Uveitis

UR - http://www.scopus.com/inward/record.url?scp=85042924691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042924691&partnerID=8YFLogxK

U2 - 10.1007/s12325-018-0672-6

DO - 10.1007/s12325-018-0672-6

M3 - Article

AN - SCOPUS:85042924691

SP - 1

EP - 18

JO - Advances in Therapy

JF - Advances in Therapy

SN - 0741-238X

ER -